Massachusetts is home to a thriving pharmaceutical industry, with leading companies pushing the boundaries of drug discovery and biopharmaceutical advancements. From cannabinoid-based therapies by Targeted Pharmaceuticals in Worcester to oncology-focused innovations by TESARO in Waltham, these firms are at the forefront of cutting-edge research in personalized medicine and biotech. Investment opportunities abound in sectors such as oncology, neurology, and antimicrobial resistance, driven by Massachusetts' robust ecosystem of publicly traded companies and dynamic startups.
VDA Pharma, Inc. specializes in the manufacturing of biopharmaceuticals focused on HIV treatment, leveraging innovative approaches to develop effective therapies in the pharmaceutical industry.
Mispro specializes in providing AAALAC-accredited contract vivarium services for preclinical rodent studies, catering to biopharmaceutical research organizations with comprehensive animal care and compliance solutions. Its innovative approach includes offering dedicated vivarium space and specialized services that enhance the efficiency of biomedical and pharmaceutical research.
Specializing in biotechnology research, Samyang Biopharm USA focuses on out-licensing innovative nucleic acid drug delivery systems and aims to establish partnerships and co-development ventures with pharmaceutical firms in the U.S.
ARIAD Pharmaceuticals specializes in pharmaceutical manufacturing with a focus on oncology and innovative drug development, leveraging biotechnology to advance cancer treatments.
Targeted Pharmaceuticals specializes in cannabinoid-based drug discovery and personalized medicine within the pharmaceutical manufacturing industry, focusing on innovative approaches to developing tailored therapeutic solutions.
Atea Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on discovering and developing innovative antiviral therapies for COVID-19 and severe viral diseases, addressing critical unmet medical needs in the biotechnology research industry.
Anthos Therapeutics is a clinical-stage biopharmaceutical entity dedicated to developing and commercializing innovative therapies for cardiovascular and metabolic diseases, leveraging a unique blend of biotech agility and pharmaceutical rigor.
Arsanis specializes in biotechnology research, focusing on innovative solutions in the pharmaceutical sector. The firm is positioned for growth following its merger with X4 Pharmaceuticals, enhancing its capabilities in developing advanced therapeutic options.
BioXchange is a leading networking organization in the biotechnology research sector, focused on connecting individuals and companies within the life sciences community through specialized events. It leverages its extensive network to foster collaboration across various industry sectors, including pharmaceuticals and drug discovery.
NeuForm Pharmaceuticals specializes in innovative drug discovery within the biopharmaceutical sector, developing proprietary and patent-protected candidates targeting oncology, neurology, immunology, and metabolic diseases. The organization emphasizes collaboration with top academic and clinical experts to deliver best-in-class medicines to patients.
Ra Pharmaceuticals specializes in pharmaceutical manufacturing, focusing on innovative therapies for rare diseases. Its unique approach includes the development of peptide-based treatments, enhancing the effectiveness and precision of drug delivery.
PharmaEssentia specializes in biotechnology research, focusing on the development of innovative biologics for hematology, oncology, and immunology, with a commitment to improving patient outcomes in rare and orphan diseases. Its unique approach combines deep scientific expertise with a dedication to advancing drug development in the biopharmaceutical sector.
An independent, academic research center focused on enhancing the quality and efficiency of pharmaceutical and biopharmaceutical development, regulation, and utilization through strategic information and innovative research. It serves as a vital resource for stakeholders in the industry, regulatory agencies, and public policy, while fostering dialogue on critical issues affecting drug development globally.
Prilenia is a clinical-stage biotechnology firm dedicated to developing innovative treatments for neurodegenerative and neurodevelopmental disorders, with a focus on its lead asset, Pridopidine, a first-in-class oral drug candidate. The firm is actively conducting advanced clinical trials for Huntington’s disease and ALS, leveraging an established safety profile to address significant unmet medical needs.
CervoMed is a clinical-stage therapeutics firm specializing in the development of CNS-focused treatments for neurodegenerative diseases, leveraging a robust development pipeline to advance innovative solutions in the pharmaceutical manufacturing industry.
Novelion Therapeutics focuses on developing innovative biopharmaceuticals aimed at establishing new standards of care for rare diseases, with a diverse portfolio that includes treatments for metabolic disorders and ongoing research into therapies for inherited retinal diseases. Their commitment to advancing science and clinical development distinguishes them in the biotechnology research industry.
A biopharmaceutical firm dedicated to innovative therapeutic solutions for serious neurological and psychiatric conditions, leveraging scientific excellence and advocacy to enhance patient outcomes. Its commitment to research and development has led to the successful commercialization of groundbreaking treatments.
Engaged in biotechnology research, Synspira Therapeutics focuses on innovative therapeutic solutions, emphasizing advancements in treatment methodologies.
Bio LIMS Inc specializes in developing innovative informatics solutions, including Laboratory Information Management Systems (LIMS) and Manufacturing Execution Systems (MES), tailored for the biotechnology and molecular biology sectors. With a focus on enhancing operational efficiency in labs and clinical environments, their offerings support a wide range of applications from genomics to cell and gene therapy.
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm specializing in the development of innovative RNA-modulating drug candidates aimed at treating rare and ultra-rare diseases caused by premature stop codons. Their lead product, ELX-02, is designed to enhance protein synthesis by enabling ribosomes to bypass these genetic mutations, addressing significant challenges in conditions like cystic fibrosis and cystinosis.
CKP Therapeutics is a biotechnology research firm dedicated to developing innovative molecules and combination therapies aimed at treating metastatic cancer and overcoming drug resistance. Its research-intensive approach positions it at the forefront of cancer therapeutics.
Accellient Partners specializes in biotechnology research, offering integrated drug development services that encompass regulatory consulting, project management, and compliance support. Their innovative approach minimizes risks and costs while accelerating development timelines, making them a preferred partner for biopharmaceutical and investment firms navigating the complex drug development landscape.
A specialist in events services, this organization facilitates live events, training, and digital resources across the biotech, pharma, MedTech, and agriculture sectors, focusing on enhancing therapeutic developments and improving patient outcomes. Its unique approach combines deep industry knowledge with custom solutions and exceptional networking opportunities, driving innovation and collaboration within the healthcare value chain.
TAC Biopharmaceuticals specializes in biotechnology research, offering a comprehensive suite of services that support the development and commercialization of biopharmaceuticals, including generic drugs and biosimilars. With over 25 years of industry experience and a strong emphasis on regulatory expertise and strategic guidance, it empowers clients to navigate the complexities of modern medicine development.
Dyax specializes in biotechnology research, focusing on innovative approaches to develop therapies for rare diseases. Its expertise in this niche area enhances its contributions to the biotechnology industry.
Aurora Biopharma, Inc. specializes in research services within the biopharmaceutical industry, focusing on innovative approaches to drug development and therapeutic solutions.
Centessa Pharmaceuticals is a clinical-stage biotechnology firm focused on discovering and developing impactful medicines across rare diseases and immuno-oncology. With a unique asset-centric approach and a robust R&D innovation engine, it aims to efficiently advance drug candidates from research to late-stage development.
NeuroCores, Inc. is a preclinical-stage biopharmaceutical firm specializing in the development of treatments for rare pediatric neurological and neurodegenerative disorders. Its innovative approach includes the use of plasmalogen derivatives, which exhibit strong anti-neuroinflammatory and neurogenesis effects, positioning the firm as a leader in addressing critical unmet medical needs in this niche market.
A leading manufacturer and service provider in biotechnology research, specializing in custom-fabricated process piping modules that enhance efficiency and productivity in biopharmaceutical processes. Their innovative approach combines engineering expertise with design capabilities to support the research and manufacturing needs of major biotech firms.
A commercial-stage biopharmaceutical entity focused on developing transformative solutions for patients with infectious diseases and challenging medical conditions, emphasizing innovative approaches to create positive health outcomes and improve patient lives.
Updated on
Save time, improve accuracy, and get ahead of the competition with Cenco.ai.
Get startedTop 25 Aircraft Fuselage Producers
Discover the top 25 aircraft fuselage producers specializing in aviation advancements across the U.S. Gain insights for strategic investments.
Top 18 CRM Software Companies in the US
Explore the top 18 CRM software companies in the US, specializing in diverse sectors from finance to healthcare. Discover tailored solutions for your business needs.
Top 23 Commercial Plumbing Specialists in Massachusetts
Explore the top 23 commercial plumbing specialists in Massachusetts, showcasing industry leaders and innovative solutions.